Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Actelion Pharmaceuticals Ltd. is a pharmaceuticals and biotechnology company established in December 1997, headquartered in Allschwil near Basel, Switzerland. The company is part of Johnson & Johnson Innovative Medicine business segment.
History, Art, Technology & Companies
Explore the main themes, entities and connections around Actelion. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
drug company patients tracleer pulmonary hypertension drugs development switzerland cotherix pah treat swiss one johnson treatment million used arterial united
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Actelion | Area served | Research and Development of medicines for unmet medical need | 1.00 | infobox |
| Actelion | Founded | 1997; 29 years ago (1997) | 1.00 | infobox |
| Actelion | Founders | Jean-Paul Clozel, Martine Clozel, Walter Fischli, André J. Müller and Thomas Widmann | 1.00 | infobox |
| Actelion | Headquarters | Gewerbestrasse 16, Allschwil, Basel-Landschaft, Switzerland | 1.00 | infobox |
| Actelion | Industry | Pharmaceuticals/Biotech | 1.00 | infobox |
| Actelion | Key people | Jean-Paul Clozel (CEO) | 1.00 | infobox |
| Actelion | Number of employees | 2,624 (2016) | 1.00 | infobox |
| Actelion | Operating income | CHF 992 million (2016) | 1.00 | infobox |
| Actelion | Parent | Johnson & Johnson | 1.00 | infobox |
| Actelion | Products | Tracleer, Ventavis, Zavesca, Veletri, Opsumit | 1.00 | infobox |
| Actelion | Revenue | CHF 2.412 billion (2016) | 1.00 | infobox |
| Actelion | Type | Subsidiary | 1.00 | infobox |
| Actelion | Website | actelion.com | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.